Substance Use & Drug Information News Briefs

December 12, 2024

CEU Course of the Week:

Treating Opioid Use Disorders



HEADLINES

Beyond abstinence: Other clinically meaningful endpoints for patients with substance use disorders (video)


Navigating Change: SAMHSA’s new federal guidelines for opioid treatment programs


Ortho-methylfentanyl proliferating across North America as newest synthetic opioid identified in fatal drug overdoses 


Psychosis risk tied to heavy cannabis use and genetic factors


NFL takes another big step toward legalizing marijuana use by players


Boosting endocannabinoids could reduce opioid addiction risk 


Study highlights need for standardized, evidence-based warning labels for cannabis products


Benzodiazepines linked to suicide, study finds 


A trusted ADHD medication has been recalled nationwide


What scientists just learned about addiction by giving rats cocaine: ‘The third group surprised us’


Alcohol use disorder, alcohol-associated liver disease up in older US adults


New mobile app launched to help people track their methamphetamine use and reduce drug-related harms


NEW PAPERS AND REPORTS


Development and Evaluation of the Global Appraisal of Individual Needs Quick Version 4 (GAIN-Q4) for ASAM Dimension Ratings and Placement Recommendations for Adolescents and Adults


 Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine


Treatment Episode Data Set (TEDS) 2022: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies 


 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic A Randomized Clinical Trial 


The Many Faces of Psilocybin-Related Psychosis: A Case Series


The rise of novel, semi-synthetic 7-hydroxymitragnine products


Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States 2021-2024 


Find more research here

 2746 Reese Avenue, 
Evanston, IL 60201
309-242-9540
Contact Us
Facebook  Twitter  Linkedin